Linden Capital Partners Successfully Completes $5.4 Billion Fund VI Fundraising Campaign

Linden Capital Partners, a prominent private equity firm based in Chicago, is celebrating a significant milestone in its history. On April 15, 2025, the firm announced the successful close of its sixth buyout fund, known as Linden Capital Partners VI (Fund VI), raising an impressive total of $5.4 billion. This includes $5.2 billion in limited partner (LP) commitments and an additional $200 million from general partners (GP). The achievement exceeds its original target of $4.5 billion and its hard cap of $5 billion, making Fund VI one of the largest fundraises in the healthcare private equity sector.

A Defining Moment for Healthcare Investment

The successful fundraising comes at a time when many firms face challenges in attracting investor funds. Despite such market difficulties, Linden’s capacity to significantly oversubscribe its latest fund illustrates the robust confidence investors have in the firm. Tony Davis, co-founder and president of Linden, acknowledged the overwhelming support from investors and described the achievement as a defining accomplishment for the firm. He emphasized the firm's commitment to facilitating impactful healthcare transformations and delivering positive outcomes for investors and healthcare stakeholders alike.

In its 20 years of operations, Linden has carved its niche as a specialist in healthcare investments, focusing on middle-market opportunities across various sectors, including healthcare services, products, and distribution. The completion of Fund VI further solidifies Linden's standing as the largest dedicated healthcare private equity firm in the industry.

Strategic Growth and Future Prospects

With the completion of Fund VI, Linden plans to continue its well-established strategy aimed at fostering long-term, sustainable growth. This includes harnessing integrated operational expertise, implementing tailored value creation programs, and leveraging a unique human capital approach to drive success in its investments. As part of this strategy, Linden underlines the importance of investing in talent and resources, boasting a dedicated team of over 60 professionals working across its various initiatives.

Katie Kornel, Linden’s Investor Relations Partner, expressed her contentment by highlighting the broad and diverse nature of the firm’s investor base, which includes partners from over 20 countries worldwide. This international reach not only reflects the firm’s reputation but also exemplifies the trust that both long-standing and new investors have in its capabilities.

Earlier this month, Linden also completed the final close of its second structured capital fund, SCF II, at $400 million, showcasing its ongoing commitment to expanding its investment strategies and capabilities.

Kirkland & Ellis LLP acted as legal counsel during this fundraising round, while PJT Park Hill and Magenta Capital Services Ltd. served as placement advisors.

About Linden Capital Partners

Founded in 2004, Linden Capital Partners operates exclusively within the healthcare sector. The firm has built an enviable portfolio, having invested in over 45 healthcare companies and completing more than 350 transactions throughout its history. Currently managing over $13.0 billion in regulatory assets, Linden continues to focus on employing its healthcare specialization and operational expertise to maximize investment returns and pursue innovative opportunities within the healthcare landscape.

For further inquiries or additional information regarding Linden Capital Partners and its ongoing projects, parties interested can visit their website at www.linden.com.